BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34248938)

  • 21. CD40L expression by CD4
    Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
    Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of CD8 and CD4 T cell responses by high viral loads.
    Fuller MJ; Zajac AJ
    J Immunol; 2003 Jan; 170(1):477-86. PubMed ID: 12496434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    Matloubian M; Concepcion RJ; Ahmed R
    J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus.
    Christensen JP; Bartholdy C; Wodarz D; Thomsen AR
    J Immunol; 2001 Mar; 166(5):3384-91. PubMed ID: 11207295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.
    Arbour N; Naniche D; Homann D; Davis RJ; Flavell RA; Oldstone MB
    J Exp Med; 2002 Apr; 195(7):801-10. PubMed ID: 11927625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A unique mechanism for innate cytokine promotion of T cell responses to viral infections.
    Pien GC; Nguyen KB; Malmgaard L; Satoskar AR; Biron CA
    J Immunol; 2002 Nov; 169(10):5827-37. PubMed ID: 12421964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
    Namineni S; O'Connor T; Faure-Dupuy S; Johansen P; Riedl T; Liu K; Xu H; Singh I; Shinde P; Li F; Pandyra A; Sharma P; Ringelhan M; Muschaweckh A; Borst K; Blank P; Lampl S; Neuhaus K; Durantel D; Farhat R; Weber A; Lenggenhager D; Kündig TM; Staeheli P; Protzer U; Wohlleber D; Holzmann B; Binder M; Breuhahn K; Assmus LM; Nattermann J; Abdullah Z; Rolland M; Dejardin E; Lang PA; Lang KS; Karin M; Lucifora J; Kalinke U; Knolle PA; Heikenwalder M
    J Hepatol; 2020 May; 72(5):960-975. PubMed ID: 31954207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.
    Shamim M; Nanjappa SG; Singh A; Plisch EH; LeBlanc SE; Walent J; Svaren J; Seroogy C; Suresh M
    J Immunol; 2007 Dec; 179(11):7233-43. PubMed ID: 18025165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 T cell-dependent CD8 T cell maturation.
    Khanolkar A; Fuller MJ; Zajac AJ
    J Immunol; 2004 Mar; 172(5):2834-44. PubMed ID: 14978084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function.
    Lercher A; Bhattacharya A; Popa AM; Caldera M; Schlapansky MF; Baazim H; Agerer B; Gürtl B; Kosack L; Májek P; Brunner JS; Vitko D; Pinter T; Genger JW; Orlova A; Pikor N; Reil D; Ozsvár-Kozma M; Kalinke U; Ludewig B; Moriggl R; Bennett KL; Menche J; Cheng PN; Schabbauer G; Trauner M; Klavins K; Bergthaler A
    Immunity; 2019 Dec; 51(6):1074-1087.e9. PubMed ID: 31784108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT5 is critical to maintain effector CD8+ T cell responses.
    Tripathi P; Kurtulus S; Wojciechowski S; Sholl A; Hoebe K; Morris SC; Finkelman FD; Grimes HL; Hildeman DA
    J Immunol; 2010 Aug; 185(4):2116-24. PubMed ID: 20644163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic viral infection on epitope selection, cytokine production, and surface phenotype of CD8 T cells and the role of IFN-gamma receptor in immune regulation.
    Tewari K; Sacha J; Gao X; Suresh M
    J Immunol; 2004 Feb; 172(3):1491-500. PubMed ID: 14734726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.
    Jennings RN; Grayson JM; Barton ES
    J Virol; 2014 Dec; 88(24):14040-9. PubMed ID: 25253356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transcription factor c-Myb regulates CD8
    Gautam S; Fioravanti J; Zhu W; Le Gall JB; Brohawn P; Lacey NE; Hu J; Hocker JD; Hawk NV; Kapoor V; Telford WG; Gurusamy D; Yu Z; Bhandoola A; Xue HH; Roychoudhuri R; Higgs BW; Restifo NP; Bender TP; Ji Y; Gattinoni L
    Nat Immunol; 2019 Mar; 20(3):337-349. PubMed ID: 30778251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen.
    Prévost-Blondel A; Neuenhahn M; Rawiel M; Pircher H
    Eur J Immunol; 2000 Sep; 30(9):2507-15. PubMed ID: 11009083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss.
    Varga SM; Selin LK; Welsh RM
    J Immunol; 2001 Feb; 166(3):1554-61. PubMed ID: 11160196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
    Apte SH; Groves P; Olver S; Baz A; Doolan DL; Kelso A; Kienzle N
    J Immunol; 2010 Jul; 185(2):998-1004. PubMed ID: 20562261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
    Wiesel M; Crouse J; Bedenikovic G; Sutherland A; Joller N; Oxenius A
    Eur J Immunol; 2012 Feb; 42(2):320-9. PubMed ID: 22102057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.
    Gracias DT; Stelekati E; Hope JL; Boesteanu AC; Doering TA; Norton J; Mueller YM; Fraietta JA; Wherry EJ; Turner M; Katsikis PD
    Nat Immunol; 2013 Jun; 14(6):593-602. PubMed ID: 23603793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.